ReviewInternational journal of molecular sciences2020

Targeting Peripherally Restricted Cannabinoid Receptor 1, Cannabinoid Receptor 2, and Endocannabinoid-Degrading Enzymes for the Treatment of Neuropathic Pain Including Neuropathic Orofacial Pain.

Mohammad Zakir Hossain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.